Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Schoppet

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 18, 2002
Molecular interactions and functional interference between vitronectin and transforming growth factor-betaMichael Schoppet, Triantafyllos Chavakis, Nadia Al-Fakhri, et al.
The Journal of Biological Chemistry|January 8, 2008
TRAIL stimulates proliferation of vascular smooth muscle cells via activation of NF-kappaB and induction of insulin-like growth factor-1 receptorMary M Kavurma, Michael Schoppet, Yuri V Bobryshev, et al.
Biochemical and Biophysical Research Communications|July 3, 2013
Monocytic expression of osteoclast-associated receptor (OSCAR) is induced in atherosclerotic mice and regulated by oxidized low-density lipoprotein in vitroKathrin Sinningen, Martina Rauner, Claudia Goettsch, et al.
Thrombosis and Haemostasis|January 18, 2006
Expression of bone-regulating factors osteoprotegerin (OPG) and receptor activator of NF-kappaB ligand (RANKL) in heterotopic vascular ossificationNadia Al-Fakhri, Lorenz C Hofbauer, Klaus T Preissner, et al.
The Journal of Clinical Endocrinology and Metabolism|March 12, 2003
Increased osteoprotegerin serum levels in men with coronary artery diseaseMichael Schoppet, Alexander M Sattler, Juergen R Schaefer, et al.
The Journal of Clinical Endocrinology and Metabolism|July 18, 2012
Endocrine and clinical correlates of myostatin serum concentration in men--the STRAMBO studyPawel Szulc, Michael Schoppet, Claudia Goettsch, et al.
Journal of Cellular Biochemistry|September 10, 2005
Atorvastatin stimulates the production of osteoprotegerin by human osteoblastsVolker Viereck, Carsten Gründker, Sabine Blaschke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2010
The role of osteoclast-associated receptor in osteoimmunologyKatharina Nemeth, Michael Schoppet, Nadia Al-Fakhri, et al.
Journal of Cellular Biochemistry|December 16, 2006
Osteoprotegerin expression in dendritic cells increases with maturation and is NF-kappaB-dependentMichael Schoppet, Stephanie Henser, Volker Ruppert, et al.
The Journal of Clinical Endocrinology and Metabolism|August 5, 2004
Osteoprotegerin gene polymorphisms in men with coronary artery diseaseMuhidien Soufi, Michael Schoppet, Alexander M Sattler, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 18, 2002
Molecular interactions and functional interference between vitronectin and transforming growth factor-betaMichael Schoppet, Triantafyllos Chavakis, Nadia Al-Fakhri, et al.
The Journal of Biological Chemistry|January 8, 2008
TRAIL stimulates proliferation of vascular smooth muscle cells via activation of NF-kappaB and induction of insulin-like growth factor-1 receptorMary M Kavurma, Michael Schoppet, Yuri V Bobryshev, et al.
Biochemical and Biophysical Research Communications|July 3, 2013
Monocytic expression of osteoclast-associated receptor (OSCAR) is induced in atherosclerotic mice and regulated by oxidized low-density lipoprotein in vitroKathrin Sinningen, Martina Rauner, Claudia Goettsch, et al.
Thrombosis and Haemostasis|January 18, 2006
Expression of bone-regulating factors osteoprotegerin (OPG) and receptor activator of NF-kappaB ligand (RANKL) in heterotopic vascular ossificationNadia Al-Fakhri, Lorenz C Hofbauer, Klaus T Preissner, et al.
The Journal of Clinical Endocrinology and Metabolism|March 12, 2003
Increased osteoprotegerin serum levels in men with coronary artery diseaseMichael Schoppet, Alexander M Sattler, Juergen R Schaefer, et al.
The Journal of Clinical Endocrinology and Metabolism|July 18, 2012
Endocrine and clinical correlates of myostatin serum concentration in men--the STRAMBO studyPawel Szulc, Michael Schoppet, Claudia Goettsch, et al.
Journal of Cellular Biochemistry|September 10, 2005
Atorvastatin stimulates the production of osteoprotegerin by human osteoblastsVolker Viereck, Carsten Gründker, Sabine Blaschke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2010
The role of osteoclast-associated receptor in osteoimmunologyKatharina Nemeth, Michael Schoppet, Nadia Al-Fakhri, et al.
Journal of Cellular Biochemistry|December 16, 2006
Osteoprotegerin expression in dendritic cells increases with maturation and is NF-kappaB-dependentMichael Schoppet, Stephanie Henser, Volker Ruppert, et al.
The Journal of Clinical Endocrinology and Metabolism|August 5, 2004
Osteoprotegerin gene polymorphisms in men with coronary artery diseaseMuhidien Soufi, Michael Schoppet, Alexander M Sattler, et al.
Pageof 5